Voyageur Pharmaceuticals Ltd
XTSX:VM

Watchlist Manager
Voyageur Pharmaceuticals Ltd Logo
Voyageur Pharmaceuticals Ltd
XTSX:VM
Watchlist
Price: 0.145 CAD Market Closed
Market Cap: CA$25.9m

Voyageur Pharmaceuticals Ltd
Other

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Voyageur Pharmaceuticals Ltd
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
Voyageur Pharmaceuticals Ltd
XTSX:VM
Other
CA$262.3k
CAGR 3-Years
97%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Other
-$105m
CAGR 3-Years
9%
CAGR 5-Years
0%
CAGR 10-Years
13%
X
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Other
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
Other
-CA$6.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-39%
Spectral Medical Inc
TSX:EDT
Other
-CA$1.9m
CAGR 3-Years
N/A
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Cipher Pharmaceuticals Inc
TSX:CPH
Other
-$50k
CAGR 3-Years
N/A
CAGR 5-Years
28%
CAGR 10-Years
38%
No Stocks Found

Voyageur Pharmaceuticals Ltd
Glance View

Market Cap
25.9m CAD
Industry
N/A

Voyageur Pharmaceuticals Ltd. engages in exploring and development of barite, iodine, and fullerene Active Pharmaceutical Ingredient (API) minerals. The company is headquartered in Calgary, Alberta. The company went IPO on 2012-05-18. The firm is focused on the development of barite and iodine Active Pharmaceutical Ingredients (API) and imaging contrast agents for the medical radiology marketplace. The company owns a 100% interest in three barium sulfate (barite) projects. The firm operates through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc. The company is focused on developing its barium sulfate project, Frances Creek, in BC, Canada for pharmaceutical barium contrast applications, such as x-radiation, computed tomography scans and magnetic resonance imaging applications. The company also owns mineral brine claims in Utah United States, including Frances Creek, Jubilee Mountain and Pedley Mountain.

VM Intrinsic Value
0.002 CAD
Overvaluation 99%
Intrinsic Value
Price

See Also

What is Voyageur Pharmaceuticals Ltd's Other?
Other
262.3k CAD

Based on the financial report for Aug 31, 2025, Voyageur Pharmaceuticals Ltd's Other amounts to 262.3k CAD.

What is Voyageur Pharmaceuticals Ltd's Other growth rate?
Other CAGR 3Y
97%

Over the last year, the Other growth was 2 847%. The average annual Other growth rates for Voyageur Pharmaceuticals Ltd have been 97% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett